R Squared LTD Annovis Bio, Inc. Transaction History
R Squared LTD
- $103 Billion
- Q4 2024
A detailed history of R Squared LTD transactions in Annovis Bio, Inc. stock. As of the latest transaction made, R Squared LTD holds 1,520 shares of ANVS stock, worth $8,056. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,520Holding current value
$8,056% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ANVS
# of Institutions
48Shares Held
1.24MCall Options Held
229KPut Options Held
934K-
Vanguard Group Inc Valley Forge, PA380KShares$2.02 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il103KShares$544,2670.0% of portfolio
-
Black Rock Inc. New York, NY101KShares$533,7570.0% of portfolio
-
Geode Capital Management, LLC Boston, MA99.1KShares$525,3040.0% of portfolio
-
Merit Financial Group, LLC98.5KShares$522,1340.01% of portfolio
About Annovis Bio, Inc.
- Ticker ANVS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,163,920
- Market Cap $43.3M
- Description
- Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease ...